Astral shares fell 2.01% to ₹1,560.00 at 01:34 pm on Friday, with the stock experiencing a decline despite reporting strong quarterly financial performance. The building materials and piping major had previously surged as much as 9.5% to an intraday high of ₹1,598.70 on Thursday following the company's strong Q1 FY27 results. The stock's performance places it among the notable losers on the Nifty Midcap 150 index, reflecting mixed investor sentiment despite the company's robust quarterly performance.
Multiple brokerages have upgraded their recommendations on Astral following the strong quarterly performance. Citi retained a Buy rating with a ₹1,900 target price, while Nuvama upgraded the stock to Buy from Hold with a revised target price of ₹1,675. Motilal Oswal maintained their Buy rating with a target price of ₹1,697, as reported in their research report dated August 12, 2026. Prabhudas Lilladher has issued a Buy rating with a target price of ₹1,684, as reported in their research report dated August 12, 2026. UBS has an Accumulate recommendation with a target price of ₹1,950, emphasizing that Astral continues to outperform peers and gain market share despite broader industry softness. The upgrades reflect confidence in the company's operational performance and market positioning.
Astral's Q1 FY27 results showed robust performance across key metrics. The company's revenue from operations stood at ₹1,578 crore, up 16% from ₹1,361 crore in the year-ago period. The company's EBITDA grew 25% year-on-year to ₹244 crore, with EBITDA margins expanding by 120 basis points to 15.5%. Despite raw material price fluctuations causing the broader piping industry to contract by around 10%, Astral managed flat volume growth, continuing to capture market share. The company's gross margin stood at 40.6%, which was impacted by partial pass through of RM cost inflation. As reported by Motilal Oswal Financial Services, the pipe EBITDA margin stood high at 18.9%, while Bathware revenue grew by 18.1%. The company reported flat plumbing volumes and 10.1% value growth, indicating continued market-share gains despite challenging polymer environment conditions.
Astral's annual financial performance demonstrates consistent growth trajectory across multiple years. Revenue has steadily increased from ₹4,394 crore in 2022 to ₹6,568.60 crore in 2026, while net profit showed an upward trend, rising from ₹492.30 crore in 2022 to ₹534.70 crore in 2026. The company's EPS improved from ₹24.08 in 2022 to ₹19.97 in 2026, with ROE maintaining healthy levels between 13.22% and 20.71% over the period. Operating cash flow remained strong at ₹1,117 crore in FY26, while net cash flow turned positive at ₹282 crore compared to negative ₹1 crore in the previous year. The company's debt-to-equity ratio remained conservative at 0.04, indicating a strong balance sheet position.
Management maintained its FY27 guidance of double-digit volume growth and more than 20% value growth in the pipe business. According to Motilal Oswal Financial Services, plumbing volumes grew ~40% YoY in July and continued to track at double-digit growth in August, supported by channel restocking and improving end-user demand. The implementation of MIP on PVC is expected to reduce polymer price volatility and improve inventory visibility. For the Adhesives business, management expects ~15–20% revenue growth in FY27, with EBITDA margins expected to recover towards 15–17% as raw-material costs soften and the impact of price hikes flows through. The UK adhesives business is expected to deliver double-digit revenue growth with EBITDA margins of 8–10% in FY27. Motilal Oswal estimates sales/EBITDA/PAT CAGR of 16%/22%/30% over FY26-28, expecting ASTRA to achieve 13.5% volume CAGR in its P&F business over FY26-28.
Motilal Oswal has retained its 'Buy' rating on Astral with a revised target price of ₹1,697, as reported in their research report dated August 12, 2026. The brokerage's recommendation is based on DCF-based valuation methodology. Prabhudas Lilladher has issued a Buy rating on Astral with a revised target price of ₹1,684 (down from ₹1,779 earlier), as reported in their research report dated August 12, 2026. The brokerage's recommendation is based on ~48x FY28E P/E valuation, with the current market valuation of ~41x FY28E P/E broadly factoring in expectations of improving financials. Despite operational numbers slightly lagging elevated expectations in adhesives, the brokerage believes Astral's core business remains best-in-class with strong fundamentals supporting the positive outlook. UBS emphasized that Astral continues to outperform peers and gain market share despite broader industry softness, with their ₹1,950 target price reflecting confidence in the company's operational execution and market positioning.
